This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cushing's Syndrome
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Working hypothesis: the interactions between the endogenous endocannabinoïds (ECS) - and cortisol, the end product of the Hypothalamo-Pituitary-Adrenal (HPA) axis may play a role in the pathophysiology of Cushing's syndrome. The investigators speculate that: - acute or chronic variations in plasma cortisol may induce changes in the activity of the ECS - that there is a circadian rhythm of the ECS driven by the rythm of plasma cortisol

Provided treatments

  • Other: Obese
  • Procedure: Hypercortisolism
  • Other: Hydrocortisone
  • Other: Control

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02889224. The sponsor of the trial is University Hospital, Bordeaux and it is looking for 40 volunteers for the current phase.
Official trial title:
In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man